The decreased SIRT1 activity inhibited deacetylation of downstream targets, including NF-κB and p53, which were highly activated by acetylation, and aggravated caerulein-induced AP through inflammation and apoptosis. The gene discussed is SIRT1; the disease is alkaline phosphatase measurement.